J
Jeffrey D. Mandell
Researcher at University of California, San Francisco
Publications - 15
Citations - 4000
Jeffrey D. Mandell is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Medicine & Exome sequencing. The author has an hindex of 8, co-authored 9 publications receiving 3148 citations.
Papers
More filters
Journal ArticleDOI
De Novo Sequence and Copy Number Variants Are Strongly Associated with Tourette Disorder and Implicate Cell Polarity in Pathogenesis.
Sheng Wang,Jeffrey D. Mandell,Yogesh Kumar,Nawei Sun,Montana T. Morris,Juan Arbelaez,Cara Nasello,Shan Dong,Clif Duhn,Xin Zhao,Zhiyu Yang,Shanmukha S. Padmanabhuni,Dongmei Yu,Robert A. King,Andrea Dietrich,Najah Khalifa,Niklas Dahl,Alden Y. Huang,Benjamin M. Neale,Giovanni Coppola,Carol A. Mathews,Jeremiah M. Scharf,Thomas V. Fernandez,Joseph D. Buxbaum,Silvia De Rubeis,D.E. Grice,Jinchuan Xing,Gary A. Heiman,Jay A. Tischfield,Peristera Paschou,A. Jeremy Willsey,Matthew W. State +31 more
TL;DR: It is found that the genes mutated in TD patients are enriched for those related to cell polarity, suggesting a common pathway underlying pathobiology, and significant overlap of de noovo sequence variants between TD and obsessive-compulsive disorder and de novo copy number variants betweenTD and autism spectrum disorder is identified.
Journal ArticleDOI
Neonatal Tbr1 Dosage Controls Cortical Layer 6 Connectivity
Siavash Fazel Darbandi,Sarah E. Robinson Schwartz,Qihao Qi,Rinaldo Catta-Preta,Emily Ling-Lin Pai,Jeffrey D. Mandell,Amanda Everitt,Anna N. Rubin,Rebecca A. Krasnoff,Sol Katzman,David Tastad,Alexander Nord,A. Jeremy Willsey,Bin Chen,Matthew W. State,Vikaas S. Sohal,John L.R. Rubenstein +16 more
TL;DR: Conditional Tbr1 deletion during late mouse gestation in cortical layer 6 neurons (Tbr1layer6 mutants) provides novel insights into its function, including dendritic patterning, synaptogenesis, and cell-intrinsic physiology, and several putative TBR1 targets are ASD risk genes.
Posted ContentDOI
Limited contribution of rare, noncoding variation to autism spectrum disorder from sequencing of 2,076 genomes in quartet families
Donna M. Werling,Harrison Brand,Joon Yong An,Matthew R. Stone,Joseph T. Glessner,Lingxue Zhu,Ryan L. Collins,Shan Dong,Ryan M. Layer,Eiriene-Chloe Markenscoff-Papadimitriou,Andrew Farrell,Grace Schwartz,Benjamin Currall,Jeanselle Dea,Clif Duhn,Carolyn A. Erdman,Michael C. Gilson,Robert E. Handsaker,Seva Kashin,Lambertus Klei,Jeffrey D. Mandell,Tomasz J. Nowakowski,Yuwen Liu,Sirisha Pochareddy,Louw Smith,Michael F. Walker,Harold Z. Wang,Mathew J Waterman,Xin He,Arnold R. Kriegstein,John L.R. Rubenstein,Nenad Sestan,Steven A. McCarroll,Neale Bm,Hilary Coon,A. Jeremy Willsey,Joseph D. Buxbaum,Mark J. Daly,Matthew W. State,Aaron R. Quinlan,Gabor T. Marth,Kathryn Roeder,Bernie Devlin,Michael E. Talkowski,Stephen Sanders +44 more
TL;DR: Assessing 51,801 regulatory classes, no category is significantly associated with ASD after correction for multiple testing, and no category of variation has impact equivalent to loss-of-function mutations.
Journal ArticleDOI
Attribution of Cancer Origins to Endogenous, Exogenous, and Preventable Mutational Processes
TL;DR: It is demonstrated that the origination of variants driving melanomas and lung cancers is predominantly attributable to the preventable, exogenous mutational processes associated with ultraviolet light and tobacco exposure, respectively, whereas the Origination of selected variants in gliomas and prostate adenocarcinomas is largely attributable to endogenous processesassociated with aging.
Journal ArticleDOI
De Novo Coding Variants Are Strongly Associated with Tourette Syndrome
Jeremy Willsey,Thomas V. Fernandez,Dongmei Yu,Robert A. King,Andrea Dietrich,Jinchuan Xing,Stephen Sanders,Jeffrey D. Mandell,Benjamin M. Neale,Giovanni Coppola,Carol A. Mathews,Jay A. Tischfield,Jeremiah M. Scharf,Matthew W. State,Gary A. Heiman +14 more
TL;DR: Recurrent de novo damaging variants and the TADA algorithm are leveraged and one high confidence (false discovery rate (FDR) variant is identified) is identified with TS risk.